Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Universiteit Antwerpen | OTHER |
| Janssen-Cilag Ltd. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The Integrated DEpression CAre (IDECA) Programme is a multi-faceted intervention strategy aiming to improve guideline adherence and shared care practices for depression management in both providers and patients, as measured through a set of process and clinical outcome indicators (primary outcome measure).
The following deliverables apply:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Integrated care arm | Experimental | Case management in primary care setting (integration at general practitioners' practices), Depression and population management education for general practitioners, shared care guidance protocol including a medication path (drug classes, no specific drugs specified, based on available depression guidelines in Belgium). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Integrated care | Other | The intervention will be modelled based on the most frequently reported patient, family physician and specialist barriers in depression management. In this project, multiple interventions aiming to tackle these barriers will be set up, with the WHO Framework on Integrated People-Centred Health Services (IPCHS) serving as conceptual backbone to the study (Table 1). The IPCHS distinguishes five interdependent strategies supporting a shift in healthcare delivery, management and funding towards universal health coverage. These strategies are:
|
| Measure | Description | Time Frame |
|---|---|---|
| Intervention integration | Nomad questionnaire (4 monthly), followed by focus groups following Balint method, and individual interviews. | 14 months |
| Measure | Description | Time Frame |
|---|---|---|
| Depression | PHQ-9 (Patient Health Questionnaire. DSM-5 depression), A PHQ-9 score total of 0-4 points equals "normal" or minimal depression. Scoring between 5-9 points indicates mild depression, 10-14 points indicates moderate depression, 15-19 points indicates moderately severe depression, and 20 or more points indicates severe depression | 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Inclusion criteria are kept broad on purpose as it's one of the research questions to define for which patients the intervention (namely the case management) is appropriate.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ruben P Willems, PhD | Contact | +32488307749 | ruben.willems@ugent.be | |
| Liesbeth Borgermans, PhD | Contact | +32473991090 | liesbeth.borgermans@ugent.be |
| Name | Affiliation | Role |
|---|---|---|
| Liesbeth Borgermans, PhD | University Ghent | Principal Investigator |
| Lieven Annemans, PhD | University Ghent | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ELZ Mechelen-Katelijne | Recruiting | Mechelen | 2800 | Belgium |
None, except anonymized data for peer review.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019033 | Delivery of Health Care, Integrated |
| ID | Term |
|---|---|
| D003695 | Delivery of Health Care |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
Not provided
Not provided
Pre/Posttest implementation study.
Not provided
Not provided
Investigators, care providers, and participants will know treatment arm allocation.
Not provided
|
| Depression and anxiety | OQ-45-2 (Outcome Questionnaire. Transdiagnostical instrument focused on anxiety and depression) Total Score
| 12 months |
| Medication adherence and self-efficacy | MARS-5 (Medication adherence report score) Each item was rated on a 5-point Likert scale, and the range of the MARS-5 total score is between 5 and 25. A higher score on the MARS-5 represents better medication adherence. <21 suboptimal adherence. MUSE (Medication Understanding and Use Self-Efficacy Scale). Score 8-32. Higher scores are better. | 12 months |
| Resource use | iMCQ (The iMTA Medical Consumption Questionnaire) to capture depression-related resource use | 12 months |
| Health-related Quality of Life | EQ5D5L (EuroQol 5 Dimensions 5 levels). Score 0 equals death and 1 perfect health. | 12 months |
| Health literacy | HLS-EU-Q16. Considering the HLS-EUQ16 score, three levels of health literacy were defined: - inadequate HL (0-8) - problematic HL (9-12) - adequate HL (13-16) | 12 months |
| ELZ Voorkempen | Recruiting | Zoersel | 2980 | Belgium |
|